Maricann Expands European Management Team and Provides Clinical Trial Update TORONTO, June 20, 2018 (GLOBE NEWSWIRE) -- Maricann Group Inc. (CSE:MARI) (FRANKFURT:75M) (OTCQB:MRRCF) (“Maricann” or the “Company) is pleased to provide the following update with regards to the Company’s European operations. () () Given the rapid expansion of the European Medical Cannabis Market, the recent…
Read more
Maricann Expands European Management Team and Provides Clinical Trial Update
